Zwingenberger K - Search Results

1

Thalidomide as salvage therapy for chronic graft-versus-host disease.

Parker PM, Chao N, Nademanee A, O'Donnell MR, Schmidt GM, Snyder DS, Stein AS, Smith EP, Molina A, Stepan DE, Kashyap A, Planas I, Spielberger R, Somlo G, Margolin K, Zwingenberger K, Wilsman K, Negrin RS, Long GD, Niland JC, Blume KG, Forman SJ. Parker PM, et al. Among authors: zwingenberger k. Blood. 1995 Nov 1;86(9):3604-9. Blood. 1995. PMID: 7579470 Free article. Clinical Trial.

2

Paradoxical effect of thalidomide prophylaxis on chronic graft-vs.-host disease.

Chao NJ, Parker PM, Niland JC, Wong RM, Dagis A, Long GD, Nademanee AP, Negrin RS, Snyder DS, Hu WW, Gould KA, Tierney DK, Zwingenberger K, Forman SJ, Blume KG. Chao NJ, et al. Among authors: zwingenberger k. Biol Blood Marrow Transplant. 1996 May;2(2):86-92. Biol Blood Marrow Transplant. 1996. PMID: 9118303 Clinical Trial.

3

Thalidomide prolongs experimental autoimmune neuritis in Lewis rats.

Zhu J, Deng GM, Diab A, Zwingenberger K, Bakhiet M, Link H. Zhu J, et al. Among authors: zwingenberger k. Scand J Immunol. 1998 Oct;48(4):397-402. doi: 10.1046/j.1365-3083.1998.00421.x. Scand J Immunol. 1998. PMID: 9790310 Free article.

4

Thalidomide in the treatment of the mucocutaneous lesions of the Behçet syndrome. A randomized, double-blind, placebo-controlled trial.

Hamuryudan V, Mat C, Saip S, Ozyazgan Y, Siva A, Yurdakul S, Zwingenberger K, Yazici H. Hamuryudan V, et al. Among authors: zwingenberger k. Ann Intern Med. 1998 Mar 15;128(6):443-50. doi: 10.7326/0003-4819-128-6-199803150-00004. Ann Intern Med. 1998. PMID: 9499327 Clinical Trial.

5

Thalidomide suppresses T- and B-cell responses to myelin antigen in experimental allergic neuritis.

Zhu J, Bai X, Mix E, van der Meide PH, Zwingenberger K, Link H. Zhu J, et al. Among authors: zwingenberger k. Clin Neuropharmacol. 1997 Apr;20(2):152-64. doi: 10.1097/00002826-199704000-00007. Clin Neuropharmacol. 1997. PMID: 9099468

6

Release of interleukin 2 and gamma interferon by peripheral mononuclear cells in human Schistosoma mansoni infection normalizes after chemotherapy.

Zwingenberger K, Irschick E, Siqueira Vergetti JG, Correia Dacal AR, Janssen-Rosseck R, Bienzle U, Huber C, Feldmeier H. Zwingenberger K, et al. Scand J Immunol. 1989 Oct;30(4):463-71. doi: 10.1111/j.1365-3083.1989.tb02451.x. Scand J Immunol. 1989. PMID: 2510291

7

Thalidomide therapy of established collagen-induced arthritis (CIA) not accompanied by an evident Th2 shift.

Hauschild A, Kroeger H, Mitchison NA, Ugrinovic S, Zwingenberger K. Hauschild A, et al. Among authors: zwingenberger k. Clin Exp Immunol. 1997 Jun;108(3):428-31. doi: 10.1046/j.1365-2249.1997.3781274.x. Clin Exp Immunol. 1997. PMID: 9182887 Free PMC article.

8

Impaired balance of interleukin-4 and interferon-gamma production in infections with Schistosoma mansoni and intestinal nematodes.

Zwingenberger K, Hohmann A, de Brito MC, Ritter M. Zwingenberger K, et al. Scand J Immunol. 1991 Aug;34(2):243-51. doi: 10.1111/j.1365-3083.1991.tb01543.x. Scand J Immunol. 1991. PMID: 1907767

9

Inhibitory effects of thalidomide on cellular proliferation, endoneurial edema and myelin phagocytosis during early wallerian degeneration.

Schröder JM, Sellhaus B, Wöhrmann T, Kögel B, Zwingenberger K. Schröder JM, et al. Among authors: zwingenberger k. Acta Neuropathol. 1995;89(5):415-9. doi: 10.1007/BF00307645. Acta Neuropathol. 1995. PMID: 7618439

10

Tumour necrosis factor in hepatosplenic schistosomiasis.

Zwingenberger K, Irschick E, Vergetti Siqueira JG, Correia Dacal AR, Feldmeier H. Zwingenberger K, et al. Scand J Immunol. 1990 Feb;31(2):205-11. doi: 10.1111/j.1365-3083.1990.tb02761.x. Scand J Immunol. 1990. PMID: 2106723

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

47 results

Search Page